Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration.

Identifieur interne : 000E89 ( Main/Corpus ); précédent : 000E88; suivant : 000E90

T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration.

Auteurs : Fernando Cruz-Guilloty ; Ali M. Saeed ; Stephanie Duffort ; Marisol Cano ; Katayoon B. Ebrahimi ; Asha Ballmick ; Yaohong Tan ; Hua Wang ; James M. Laird ; Robert G. Salomon ; James T. Handa ; Victor L. Perez

Source :

RBID : pubmed:24586307

English descriptors

Abstract

Age-related macular degeneration (AMD) is a major disease affecting central vision, but the pathogenic mechanisms are not fully understood. Using a mouse model, we examined the relationship of two factors implicated in AMD development: oxidative stress and the immune system. Carboxyethylpyrrole (CEP) is a lipid peroxidation product associated with AMD in humans and AMD-like pathology in mice. Previously, we demonstrated that CEP immunization leads to retinal infiltration of pro-inflammatory M1 macrophages before overt retinal degeneration. Here, we provide direct and indirect mechanisms for the effect of CEP on macrophages, and show for the first time that antigen-specific T cells play a leading role in AMD pathogenesis. In vitro, CEP directly induced M1 macrophage polarization and production of M1-related factors by retinal pigment epithelial (RPE) cells. In vivo, CEP eye injections in mice induced acute pro-inflammatory gene expression in the retina and human AMD eyes showed distinctively diffuse CEP immunolabeling within RPE cells. Importantly, interferon-gamma (IFN-γ) and interleukin-17 (IL-17)-producing CEP-specific T cells were identified ex vivo after CEP immunization and promoted M1 polarization in co-culture experiments. Finally, T cell immunosuppressive therapy inhibited CEP-mediated pathology. These data indicate that T cells and M1 macrophages activated by oxidative damage cooperate in AMD pathogenesis.

DOI: 10.1371/journal.pone.0088201
PubMed: 24586307
PubMed Central: PMC3929609

Links to Exploration step

pubmed:24586307

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration.</title>
<author>
<name sortKey="Cruz Guilloty, Fernando" sort="Cruz Guilloty, Fernando" uniqKey="Cruz Guilloty F" first="Fernando" last="Cruz-Guilloty">Fernando Cruz-Guilloty</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America ; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Saeed, Ali M" sort="Saeed, Ali M" uniqKey="Saeed A" first="Ali M" last="Saeed">Ali M. Saeed</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Duffort, Stephanie" sort="Duffort, Stephanie" uniqKey="Duffort S" first="Stephanie" last="Duffort">Stephanie Duffort</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cano, Marisol" sort="Cano, Marisol" uniqKey="Cano M" first="Marisol" last="Cano">Marisol Cano</name>
<affiliation>
<nlm:affiliation>Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ebrahimi, Katayoon B" sort="Ebrahimi, Katayoon B" uniqKey="Ebrahimi K" first="Katayoon B" last="Ebrahimi">Katayoon B. Ebrahimi</name>
<affiliation>
<nlm:affiliation>Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ballmick, Asha" sort="Ballmick, Asha" uniqKey="Ballmick A" first="Asha" last="Ballmick">Asha Ballmick</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tan, Yaohong" sort="Tan, Yaohong" uniqKey="Tan Y" first="Yaohong" last="Tan">Yaohong Tan</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wang, Hua" sort="Wang, Hua" uniqKey="Wang H" first="Hua" last="Wang">Hua Wang</name>
<affiliation>
<nlm:affiliation>Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Laird, James M" sort="Laird, James M" uniqKey="Laird J" first="James M" last="Laird">James M. Laird</name>
<affiliation>
<nlm:affiliation>Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Salomon, Robert G" sort="Salomon, Robert G" uniqKey="Salomon R" first="Robert G" last="Salomon">Robert G. Salomon</name>
<affiliation>
<nlm:affiliation>Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Handa, James T" sort="Handa, James T" uniqKey="Handa J" first="James T" last="Handa">James T. Handa</name>
<affiliation>
<nlm:affiliation>Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Perez, Victor L" sort="Perez, Victor L" uniqKey="Perez V" first="Victor L" last="Perez">Victor L. Perez</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America ; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24586307</idno>
<idno type="pmid">24586307</idno>
<idno type="doi">10.1371/journal.pone.0088201</idno>
<idno type="pmc">PMC3929609</idno>
<idno type="wicri:Area/Main/Corpus">000E89</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000E89</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration.</title>
<author>
<name sortKey="Cruz Guilloty, Fernando" sort="Cruz Guilloty, Fernando" uniqKey="Cruz Guilloty F" first="Fernando" last="Cruz-Guilloty">Fernando Cruz-Guilloty</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America ; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Saeed, Ali M" sort="Saeed, Ali M" uniqKey="Saeed A" first="Ali M" last="Saeed">Ali M. Saeed</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Duffort, Stephanie" sort="Duffort, Stephanie" uniqKey="Duffort S" first="Stephanie" last="Duffort">Stephanie Duffort</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cano, Marisol" sort="Cano, Marisol" uniqKey="Cano M" first="Marisol" last="Cano">Marisol Cano</name>
<affiliation>
<nlm:affiliation>Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ebrahimi, Katayoon B" sort="Ebrahimi, Katayoon B" uniqKey="Ebrahimi K" first="Katayoon B" last="Ebrahimi">Katayoon B. Ebrahimi</name>
<affiliation>
<nlm:affiliation>Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ballmick, Asha" sort="Ballmick, Asha" uniqKey="Ballmick A" first="Asha" last="Ballmick">Asha Ballmick</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tan, Yaohong" sort="Tan, Yaohong" uniqKey="Tan Y" first="Yaohong" last="Tan">Yaohong Tan</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wang, Hua" sort="Wang, Hua" uniqKey="Wang H" first="Hua" last="Wang">Hua Wang</name>
<affiliation>
<nlm:affiliation>Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Laird, James M" sort="Laird, James M" uniqKey="Laird J" first="James M" last="Laird">James M. Laird</name>
<affiliation>
<nlm:affiliation>Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Salomon, Robert G" sort="Salomon, Robert G" uniqKey="Salomon R" first="Robert G" last="Salomon">Robert G. Salomon</name>
<affiliation>
<nlm:affiliation>Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Handa, James T" sort="Handa, James T" uniqKey="Handa J" first="James T" last="Handa">James T. Handa</name>
<affiliation>
<nlm:affiliation>Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Perez, Victor L" sort="Perez, Victor L" uniqKey="Perez V" first="Victor L" last="Perez">Victor L. Perez</name>
<affiliation>
<nlm:affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America ; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Biological Transport (drug effects)</term>
<term>Cyclosporine (pharmacology)</term>
<term>Disease Models, Animal (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Immunization (MeSH)</term>
<term>Interferon-gamma (biosynthesis)</term>
<term>Interleukin-7 (biosynthesis)</term>
<term>Macrophages (cytology)</term>
<term>Macrophages (immunology)</term>
<term>Macular Degeneration (etiology)</term>
<term>Macular Degeneration (immunology)</term>
<term>Macular Degeneration (metabolism)</term>
<term>Male (MeSH)</term>
<term>Mice (MeSH)</term>
<term>Oxidative Stress (immunology)</term>
<term>Pyrroles (metabolism)</term>
<term>Retinal Pigment Epithelium (drug effects)</term>
<term>Retinal Pigment Epithelium (immunology)</term>
<term>Retinal Pigment Epithelium (metabolism)</term>
<term>Sirolimus (pharmacology)</term>
<term>T-Lymphocytes (cytology)</term>
<term>T-Lymphocytes (immunology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Interferon-gamma</term>
<term>Interleukin-7</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Pyrroles</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Cyclosporine</term>
<term>Sirolimus</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Macrophages</term>
<term>T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Biological Transport</term>
<term>Retinal Pigment Epithelium</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Macular Degeneration</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Macrophages</term>
<term>Macular Degeneration</term>
<term>Oxidative Stress</term>
<term>Retinal Pigment Epithelium</term>
<term>T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Macular Degeneration</term>
<term>Retinal Pigment Epithelium</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Humans</term>
<term>Immunization</term>
<term>Male</term>
<term>Mice</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Age-related macular degeneration (AMD) is a major disease affecting central vision, but the pathogenic mechanisms are not fully understood. Using a mouse model, we examined the relationship of two factors implicated in AMD development: oxidative stress and the immune system. Carboxyethylpyrrole (CEP) is a lipid peroxidation product associated with AMD in humans and AMD-like pathology in mice. Previously, we demonstrated that CEP immunization leads to retinal infiltration of pro-inflammatory M1 macrophages before overt retinal degeneration. Here, we provide direct and indirect mechanisms for the effect of CEP on macrophages, and show for the first time that antigen-specific T cells play a leading role in AMD pathogenesis. In vitro, CEP directly induced M1 macrophage polarization and production of M1-related factors by retinal pigment epithelial (RPE) cells. In vivo, CEP eye injections in mice induced acute pro-inflammatory gene expression in the retina and human AMD eyes showed distinctively diffuse CEP immunolabeling within RPE cells. Importantly, interferon-gamma (IFN-γ) and interleukin-17 (IL-17)-producing CEP-specific T cells were identified ex vivo after CEP immunization and promoted M1 polarization in co-culture experiments. Finally, T cell immunosuppressive therapy inhibited CEP-mediated pathology. These data indicate that T cells and M1 macrophages activated by oxidative damage cooperate in AMD pathogenesis. </div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">24586307</PMID>
<DateCompleted>
<Year>2014</Year>
<Month>12</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>9</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS One</ISOAbbreviation>
</Journal>
<ArticleTitle>T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration.</ArticleTitle>
<Pagination>
<MedlinePgn>e88201</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0088201</ELocationID>
<Abstract>
<AbstractText>Age-related macular degeneration (AMD) is a major disease affecting central vision, but the pathogenic mechanisms are not fully understood. Using a mouse model, we examined the relationship of two factors implicated in AMD development: oxidative stress and the immune system. Carboxyethylpyrrole (CEP) is a lipid peroxidation product associated with AMD in humans and AMD-like pathology in mice. Previously, we demonstrated that CEP immunization leads to retinal infiltration of pro-inflammatory M1 macrophages before overt retinal degeneration. Here, we provide direct and indirect mechanisms for the effect of CEP on macrophages, and show for the first time that antigen-specific T cells play a leading role in AMD pathogenesis. In vitro, CEP directly induced M1 macrophage polarization and production of M1-related factors by retinal pigment epithelial (RPE) cells. In vivo, CEP eye injections in mice induced acute pro-inflammatory gene expression in the retina and human AMD eyes showed distinctively diffuse CEP immunolabeling within RPE cells. Importantly, interferon-gamma (IFN-γ) and interleukin-17 (IL-17)-producing CEP-specific T cells were identified ex vivo after CEP immunization and promoted M1 polarization in co-culture experiments. Finally, T cell immunosuppressive therapy inhibited CEP-mediated pathology. These data indicate that T cells and M1 macrophages activated by oxidative damage cooperate in AMD pathogenesis. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cruz-Guilloty</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America ; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saeed</LastName>
<ForeName>Ali M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duffort</LastName>
<ForeName>Stephanie</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cano</LastName>
<ForeName>Marisol</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ebrahimi</LastName>
<ForeName>Katayoon B</ForeName>
<Initials>KB</Initials>
<AffiliationInfo>
<Affiliation>Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ballmick</LastName>
<ForeName>Asha</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Yaohong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Hua</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laird</LastName>
<ForeName>James M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salomon</LastName>
<ForeName>Robert G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Handa</LastName>
<ForeName>James T</ForeName>
<Initials>JT</Initials>
<AffiliationInfo>
<Affiliation>Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Perez</LastName>
<ForeName>Victor L</ForeName>
<Initials>VL</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States of America ; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 EY019904</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 EY014801</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>EY14005</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EY014005</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EY016813</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<Agency>Howard Hughes Medical Institute</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30EY14801</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-GM21249</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>EY019904</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>02</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015851">Interleukin-7</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011758">Pyrroles</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>82115-62-6</RegistryNumber>
<NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>83HN0GTJ6D</RegistryNumber>
<NameOfSubstance UI="D016572">Cyclosporine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>W36ZG6FT64</RegistryNumber>
<NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001692" MajorTopicYN="N">Biological Transport</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016572" MajorTopicYN="N">Cyclosporine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015851" MajorTopicYN="N">Interleukin-7</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008268" MajorTopicYN="N">Macular Degeneration</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011758" MajorTopicYN="N">Pyrroles</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055213" MajorTopicYN="N">Retinal Pigment Epithelium</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2013</Year>
<Month>10</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2014</Year>
<Month>01</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>3</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>3</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>12</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24586307</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0088201</ArticleId>
<ArticleId IdType="pii">PONE-D-13-44150</ArticleId>
<ArticleId IdType="pmc">PMC3929609</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Cell Rep. 2012 Nov 29;2(5):1151-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23177625</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Ophthalmol. 1990 Oct;108(10):1442-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1699513</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Apr 15;308(5720):419-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15761120</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Prog Neurobiol. 2011 Sep 15;95(1):14-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21740956</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2004 Aug;114(3):427-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15286809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2010 Oct;11(10):889-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20856220</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2012 Mar;122(3):787-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22378047</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Transl Med. 2011;9:1-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21762495</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Apr 15;308(5720):421-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15761121</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2008 Nov 22;372(9652):1835-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19027484</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Aspects Med. 2012 Aug;33(4):418-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22503691</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2006 Aug;3(8):e310</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16903779</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2011 Oct 6;478(7367):76-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21979047</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ocul Immunol Inflamm. 2012 Feb;20(1):27-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22324898</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Apr 15;308(5720):385-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15761122</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunity. 2010 Jan 29;32(1):79-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20096607</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2011 Oct 6;478(7367):42-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21979040</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Inflam. 2013;2013:503725</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23533946</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2012 Nov;13(11):1037-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23080204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2013 Jun;13(6):438-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23702979</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2010 Oct 21;467(7318):972-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20927103</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Ophthalmol. 2010 Jul;94(7):918-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19965817</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuron. 2012 Jul 12;75(1):26-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22794258</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Biosci. 2004 Jan 1;9:411-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14766378</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mediators Inflamm. 2012;2012:546786</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23209345</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2013 Apr 2;17(4):549-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23562078</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Ophthalmol. 2007 Oct;144(4):618-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17698021</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14292-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20660725</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15870199</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2007 Nov;117(11):3421-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17975672</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14682-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12391305</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Mol Pathol. 2012 Feb;92(1):64-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22001380</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Comp Biochem Physiol B Biochem Mol Biol. 1998 Aug;120(4):785-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9854823</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2007 Aug 9;357(6):553-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17634448</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7749-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12802010</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trans Ophthalmol Soc U K. 1980 Sep;100(3):414-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6171074</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2010 Jun;41(2-3):290-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20221855</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2012 Nov;12(11):749-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23080391</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2008 Feb;14(2):194-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18223656</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Mol Pathol. 2012 Oct;93(2):193-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22465421</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2003 Oct 24;278(43):42027-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12923198</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pathol Int. 2011 Sep;61(9):528-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21884302</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Investig Drugs. 2009 May;10(5):434-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19431076</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Genet. 2006 Apr;38(4):458-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16518403</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Exp Med Biol. 2010;664:411-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20238042</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2003 Nov;9(11):1390-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14566334</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2012 May;18(5):791-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22484808</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Ophthalmol. 2004 Jul;122(7):1013-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15249366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2011 Jan;121(1):369-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21135502</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ophthalmology. 2013 Nov;120(11):2310-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23747161</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autoimmun. 2009 Nov-Dec;33(3-4):247-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19846275</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2008 Apr 14;205(4):799-810</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18391061</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Rev. 2009 Jan;227(1):221-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19120487</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circ Res. 2010 Sep 17;107(6):737-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20651288</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2010 Jan 15;327(5963):291-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20075244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Inflam. 2013;2013:348092</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23762772</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2013 Jan;123(1):27-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23281407</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2010 Sep;120(9):3033-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20811159</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bioorg Med Chem. 2009 Nov 1;17(21):7548-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19786352</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2010 May 10;207(5):1081-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20439543</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E89 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000E89 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:24586307
   |texte=   T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:24586307" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020